Results 181 to 190 of about 55,007 (211)

Therapies for Cardiovascular‐Kidney‐Liver‐Metabolic Syndrome: Reappraisal of Fibrates

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Cardiovascular disease, chronic kidney disease (CKD), type 2 diabetes mellitus (T2DM), obesity and metabolic dysfunction‐associated steatohepatitis (MASH) frequently coexist and share overlapping pathophysiology, forming the proposed cardiovascular‐kidney‐liver‐metabolic (CKLM) syndrome.
Virginia Anagnostopoulou, Christoforos K. Travlos, Lucas Lage Marinho, Thomas A. Mavrakanas, João Pedro Ferreira, Abhinav Sharma   +5 more
wiley   +1 more source

Innovative discovery and validation of ACE-inhibitory peptides from eggshell membrane keratin byproducts: An integrated computational and <i>in vitro</i> approach. [PDF]

Curr Res Food Sci
Xu T, Yang J, Gong L, Li H, Zhao K, Wang Z, Tang H.   +6 more
europepmc   +1 more source

Evaluating Whole Fruit Feijoa Powder for Type 2 Diabetes Risk Prevention: A Randomised Controlled Trial

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Background Low energy diets (LEDs) are effective for body weight (BW) loss and improvement of type 2 diabetes (T2D) risk biomarkers. Emerging evidence suggests that whole fruit feijoa powder, rich in polyphenols and abscisic acid, may further support T2D prevention.
I. A. Mohamed, I. R. Sequeira‐Bisson, J. J. Lim, L. D. Plank, R. Murphy, S. D. Poppitt, J. L. Miles‐Chan   +6 more
wiley   +1 more source

Lactobacilli-Fermented Chia Seeds as a Potential Anti-Hypertensive Agent. [PDF]

Molecules
Atonal-Sánchez H, Cornejo-Garrido J, Rivera-Orduña FN, Villa-Ruano N, García-Díaz LE, Rangel-Galván M, Luna-Suárez S.   +6 more
europepmc   +1 more source

The SGLT2i Treatment Gap in UK Primary Care: A Cross‐Sectional RWE Study of Prescribing in Clinical Practice

Diabetes, Obesity and Metabolism, EarlyView.
ABSTRACT Aims Sodium‐glucose co‐transporter 2 inhibitors (SGLT2i) improve cardiovascular and renal outcomes in type 2 diabetes mellitus (T2DM), chronic kidney disease (CKD) and chronic heart failure (CHF). Despite clinical guideline recommendations, SGLT2i uptake in UK primary care remains suboptimal and information on utilisation is limited.
Chelsea Stefanska, Ryan Chung, Salman Ramjaun, Danyao Jin, Ciara Doherty, Kieran McCafferty, Samuel Seidu   +6 more
wiley   +1 more source

New variants in ACE gene region in 10 Cavalier King Charles Spaniel dogs with mild and severe myxomatous mitral valve disease - preliminary study. [PDF]

Vet Anim Sci
Lewicki M, Górczyńska-Kosiorz S, Frydrychowski P, Gach J, Wojtczak Z, Cymbryłowicz J, Noszczyk-Nowak A.   +6 more
europepmc   +1 more source

Characterization of the myocardial and renal renin-angiotensin system in normal cats and cats with hypertrophic cardiomyopathy. [PDF]

J Vet Intern Med
Wood JE, Ames MK, Kaplan JL, Rivas V, Wilson MD, Domenig O, Stern JA.   +6 more
europepmc   +1 more source

Valorization of Whey into a Bioactive Hydrolysate with ACE-Inhibitory Activity and Food Application Potential. [PDF]

Foods
Fellenberg MA, Silva-Vera W, Panes O, Abarca RL.   +3 more
europepmc   +1 more source

Dashboard-Directed Intervention to Improve Guideline-Directed Heart Failure Therapy for Veterans. [PDF]

JACC Adv
Sheng Q, Brownell NK, Hsu JJ, Chang DS, Fonarow GC, Ziaeian B.   +5 more
europepmc   +1 more source